← Leaderboards
Youngkyu Park
Kansas State University
$2,593,859
Attributed
$2,593,859
Total exposure
15
Grants
15
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $248K · FY2008–25$250K$187.5K$125K$62.5K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,593,859 · 15
By mechanism
R50$2,110,810 · 1
P41$295,083 · 12
P20$187,966 · 2
Top collaborators
No co-investigators on record.
Most similar at Kansas State University
Same institution · by research overlap
- Punit Prakash$2,635,726
- Daniel C Marcus$6,366,219
- Christine M Aikens$1,890,596
- Punit Prakash$1,558,788
Others in their field
Top investigators on “United States National Institutes Of Health”
- Leonard Freedman · Leidos Biomedical Research, Inc.$816,847,401
- Sonia M Thomas · Research Triangle Institute$701,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$642,073,624
- Bambra Strokes · Ppd Development Lp$526,656,217
- Lawrence Corey · Fred Hutchinson Cancer Center$513,687,120
- Tracy L Nolen · Research Triangle Institute$474,487,152
Research focus
United States National Institutes Of HealthSourceGrantResourcesFundingComputer Retrieval Of Information On Scientific Projects DatabaseErythrocytesInstitutionResearch PersonnelCell MembraneMicroscopyMembraneNovel Therapeutic InterventionOrganoidsGenesMouse ModelPancreatic Ductal AdenocarcinomaPre-Clinical ModelPathway InteractionsProteomicsIn VivoMalignant NeoplasmsCancer CellGenetically Engineered Mouse
Grant awards (24)
Preclinical Models for Cancer Therapeutic Development$248,045
R50 · FY2025 · CA · contact PI
Preclinical Models for Cancer Therapeutic Development$248,045
R50 · FY2024 · CA · contact PI
Preclinical Models for Cancer Therapeutic Development$248,045
R50 · FY2023 · CA · contact PI
Preclinical Models for Cancer Therapeutic Development$248,045
R50 · FY2022 · CA · contact PI
Preclinical Models for Cancer Therapeutic Development$248,045
R50 · FY2021 · CA · contact PI
Preclinical Models for Cancer Therapeutic Development$174,117
R50 · FY2020 · CA · contact PI
Preclinical Models for Cancer Therapeutic Development$174,117
R50 · FY2019 · CA · contact PI
Preclinical Models for Cancer Therapeutic Development$174,117
R50 · FY2018 · CA · contact PI
Preclinical Models for Cancer Therapeutic Development$174,117
R50 · FY2017 · CA · contact PI
Preclinical Models for Cancer Therapeutic Development$174,117
R50 · FY2016 · CA · contact PI
MEMBRANE FLUCTUATIONS OF RED BLOOD CELLS WITH DIFFRACTION PHASE MICROSCOPY$22,301
P41 · FY2011 · RR · contact PI
DYNAMICS OF RED BLOOD CELLS INFECTED BY P FALCIPARUM$22,301
P41 · FY2011 · RR · contact PI
METABOLIC REMODELING OF THE HUMAN RED BLOOD CELL MEMBRANE$22,301
P41 · FY2011 · RR · contact PI
MEMBRANE FLUCTUATIONS OF RED BLOOD CELLS WITH DIFFRACTION PHASE MICROSCOPY$28,488
P41 · FY2010 · RR · contact PI
DYNAMICS OF RED BLOOD CELLS INFECTED BY P FALCIPARUM$28,488
P41 · FY2010 · RR · contact PI
SPECTROSCOPIC PHASE MICROSCOPY$18,992
P41 · FY2010 · RR · contact PI
SPECKLE FIELD PHASE MICROSCOPY$18,992
P41 · FY2010 · RR · contact PI
METABOLIC REMODELING OF THE HUMAN RED BLOOD CELL MEMBRANE$18,992
P41 · FY2010 · RR · contact PI
TRANSEPITHELIAL ION TRANSPORT IN MOSQUITO HINDGUT CONTROLLED BY PEPTIDE HORMONE$29,187
P20 · FY2009 · RR · contact PI
MEMBRANE FLUCTUATIONS OF RED BLOOD CELLS WITH DIFFRACTION PHASE MICROSCOPY$28,535
P41 · FY2009 · RR · contact PI
DYNAMICS OF RED BLOOD CELLS INFECTED BY P FALCIPARUM$28,535
P41 · FY2009 · RR · contact PI
TRANSEPITHELIAL ION TRANSPORT IN MOSQUITO HINDGUT CONTROLLED BY PEPTIDE HORMONE$158,779
P20 · FY2008 · RR · contact PI
MEMBRANE FLUCTUATIONS OF RED BLOOD CELLS WITH DIFFRACTION PHASE MICROSCOPY$28,579
P41 · FY2008 · RR · contact PI
DYNAMICS OF RED BLOOD CELLS INFECTED BY P FALCIPARUM$28,579
P41 · FY2008 · RR · contact PI